Generics

Mexico: new links between patents and pharmaceuticals

A new facet of Mexico’s linkage system between patents and pharmaceutical drugs raises several questions that necessitate a careful approach from patent assignees and agents, as Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reports.

• Generic competition: when one door closes, another opens 26-10-2018
• I-MAK: saving lives by curing the patent system 19-10-2018
• SPC waiver: good intentions, but not the right deal? 17-10-2018
• USITC: a powerful forum for biologics patent owners 10-10-2018
• A patent attack on three fronts 02-10-2018

More generics features